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Abstract
Motivation: Antibodies are widely used reagents to test for expression of proteins. However, they might not
always reliably produce results when they do not specifically bind to the target proteins that their providers
designed them for, leading to unreliable research results. While many proposals have been developed to
deal with the problem of antibody specificity, they may not scale well to deal with the millions of antibodies
that are available to researchers. In this study, we investigate the feasibility of automatically generating a
report to alert users of problematic antibodies by extracting statements about antibody specificity reported
in the literature.
Results: Our goal is to construct an “Antibody Watch” knowledge base containing supporting statements
of problematic antibodies. We developed a deep neural network system and tested its performance with a
corpus of more than two thousand articles that reported uses of antibodies. We divided the problem into
two tasks. Given an input article, the first task is to identify snippets about antibody specificity and classify
if the snippets report that any antibody exhibits nonspecificity, and thus is problematic. The second task
is to link each of these snippets to one or more antibodies mentioned in the snippet. The experimental
evaluation shows that our system can accurately perform both classification and linking tasks with weighted
F-scores over 0.925 and 0.923, respectively, and 0.914 overall when combined to complete the joint task.
We leveraged Research Resource Identifiers (RRID) to precisely identify antibodies linked to the extracted
specificity snippets. The result shows that it is feasible to construct a reliable knowledge base about
problematic antibodies by text mining.
Availability: GitHub: SciCrunch/Antibody-Watch. Zenodo: doi:10.5281/zenodo.3701930.
Contact: chunnan@ucsd.edu
Supplementary information: https://scicrunch.github.io/Antibody-Watch/
1 Introduction
Antibodies are some of the most common and powerful experimental
reagents for detection and localization of proteins, peptides, polysaccharides,
and other antigens. They are essential in biomedical research. In an
immune system, an antibody binds to an antigen with the top tips of its
Y-shaped chemical structure. Scientists take advantage of this property to
design antibodies that target specific antigens to detect their presence or
to isolate them from a mixture. Examples of common antibody assays
include immunohistochemistry (IHC, Ramos-Vara and Miller 2014),
western blot (WB, Burnette 1981), flow cytometry (FC, Cossarizza et al.
2017), and enzyme-linked immunosorbent assay (ELISA, Engvall and
Perlmann 1971). Antibodies are playing an important role in studies of
COVID-19. Over 281 unique antibodies are associated with COVID-19,
according to the Antibody Registry (https://antibodyregistry.
org/covid19).
One of the most common antibody problems is that the antibody may
not bind only to the antigen that their providers design them for, known as
the problem of antibody specificity (Uhlen et al., 2016; Baker, 2015). There
may be cross reactivity due to design flaws, contamination, or use in a novel
context where a similar antigen is detected. While clinical antibodies can
be tested for the exact application for which they are indicated, research-
use only antibodies will be tested typically in one or more applications in
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one or a small handful of species, but it is nearly impossible to test them
in all species or under all conditions in which they can potentially be used.
Therefore, these reagents, while specific in a mouse colon, for example,
may have specificity issues when tested for the same target antigen in a
zebrafish brain. An experiment using a nonspecific antibody may lead to
misinterpretation of the results, leading to inaccurate conclusions.
Many have proposed systematic validation of antibodies, including
experimental validation by large consortium projects such as the
Antibody Validation Database (Egelhofer et al., 2011) from the ENCODE
project (Davis et al., 2018) or the independent validation project (Bordeaux
et al., 2010); feedback collection, such as the BioCompare Antibody
Search Tool (https://www.biocompare.com/Antibodies)
and AntibodyPedia (https://www.antibodypedia.com); and
curation based on figures of antibody experimental results reported in
the literature, such as BenchSci (https://www.benchsci.com).
However, because there are more than two million unique antibodies,
according to the Antibody Registry, and new ones are constantly made,
these types of efforts may not scale well. Therefore, many problems with
antibodies are only encountered in the context of individual studies, where
authors work to validate antibodies before use and may report problems
with some reagents.
We propose to address the antibody specificity problem by constructing
a knowledge base containing statements about antibody specificity
automatically extracted from the biomedical literature. A large number
of statements about antibody specificity are available by authors who used
antibodies in their experiments. Automated text mining techniques can be
applied to extract and disseminate the information at a scale that matches
the growth rate of new antibodies and publications to provide scientists
up-to-date alerts of problematic antibodies to assist their selection of
antibodies. The key contributions of this work include:
• We propose a novel approach to the problem of antibody specificity by
alerting scientists if an antibody is well validated or may be problematic
as reported in the literature. The problem is important in helping ensure
reliability of studies using antibodies in the experiments.
• We show that the approach is feasible by developing an automated
text mining system called (ABSA)2 and empirically evaluate its
performance with an in-house annotated corpus of ∼2,000 articles.
(ABSA)2, which stands for AntiBody Specificity Annotator by
Aspect-Based Sentiment Analysis, is a deep neural network model that
distinguishes specificity of antibodies stated in a snippet. (ABSA)2
achieves the best F-score for the task of identifying problematic
antibodies in our experimental evaluation, outperforming all baselines
and competing models.
• We show that with our automated text mining system, combining
author-supplied Research Resource Identifier (RRID, Bandrowski
et al. 2014, 2015, 2016; Bandrowski and Martone 2016) with advanced
deep neural network Natural Language Processing (NLP), we can
unambiguously identify an antibody mentioned in the literature,
allowing us to link an antibody specificity statement automatically
extracted from the literature with an exact antibody referred to
by the statement. This is crucial in order to provide useful alerts
of problematic antibodies. We anticipate that similar RRID-NLP
hybrid text mining approaches can be applied to quantify qualities
and appropriate usages of biomedical research resources covered
by the RRID, including, e.g., cell lines, bioinformatics tools, data
repositories, etc., and properly credit developers of these research
resources, a long standing issue of modern biomedical research that
depends heavily on research resources (Vasilevsky et al., 2013; Smith
et al., 2016; Bandrowski and Martone, 2016; Hsu et al., 2017; Babic
et al., 2019).
2 System and methods
Our goal is to construct a knowledge base called “Antibody Watch” as a part
of our “Resource Watch” services in dkNET (https://dknet.org)
for scientist users to check if the antibody they are interested in has
been reported in the literature and if any information has been provided
about its specificity with regard to its designated target antigen. In our
vision, “Resource Watch” will cover a broad range of biomedical research
resources in addition to antibodies, such as cell lines, model organisms,
bioinformatics tools, and data repositories, etc. “Antibody Watch” will
focus on antibodies and provide for each unique antibody, a list of
statements extracted from the literature about its specificity, along with
metadata about the antibody to facilitate search. Table 1 shows example
snippets from real publications that contain keywords related to “antibody”
(colored in red) and “specific” (in blue) and are potentially the statements
that we would like to extract to include in our knowledge base. We
classify such snippet into one of the following classes: nonspecific, specific
and neutral. Those snippets classified as nonspecific and specific will be
included in the knowledge base while neutral ones will be excluded.
Their definitions are:
• Nonspecific (Negative): the snippet states that an antibody may not
always be specific to its target antigen and thus problematic.
• Specific (Positive): the snippet states that an antibody is specific to its
target antigen.
• Neutral: all other snippets that are not about whether the antibody is
specific to its target antigen and thus irrelevant for our purposes.
The problem is related to sentiment analysis that has been intensively
studied in NLP, driven by the need of automatically classifying the
sentiment of online customer product/service reviews. State-of-the-art
approaches can classify not only the overall sentiment of a review but
the sentiment of a designated aspect (e.g., “appetizer” of restaurants) by
leveraging attention mechanisms of deep neural networks (e.g., (Huang
et al., 2018; Zeng et al., 2019; Song et al., 2019)). We leveraged these ideas
to develop effective classifiers for our antibody specificity classification
task.
In the last decade, many approaches to aspect-based sentiment analysis
(ABSA) have been developed ranging from statistical machine learning
methods (Schouten and Frasincar, 2016) to deep learning models (Zhou
et al., 2019). For example, Wang et al. (2016) developed an attention-based
BiLSTM model (Graves and Schmidhuber, 2005). Huang et al. (2018)
introduced an attention-over-attention (AOA) neural network to capture
the interaction between aspects and context sentences. The AOA model
outperformed previous BiLSTM-based architectures. A comprehensive
survey of ABSA can be found in (Zhou et al., 2019).
Once a snippet is extracted and classified as an antibody specificity
statement, we need to link the statement to the exact antibody entities
Table 1. Example snippets of the antibody specificity classes.
Class Example
Nonspecific Some non-specific bands were detected at ~55 kDa
(Negative) in both WT and APP/PS1 mice with the 6E10 antibody …
Specific Our antibody is specific, as each immunizing peptide
(Positive) blocked the corresponding immunoreactivity …
Neutral Probing protein arrays with antibodies allows the
assessment of their specificity and cross-reactivity across
a large numbers of potential antigens in parallel …
i
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referred to in the statement. The task is challenging because antibody
references are obscure (Uhlen et al., 2016; Hoek et al., 2020). Many
antibody providers exist, including commercial suppliers and academic
research labs of various sizes. For any given antigen, there can be
many antibodies from different suppliers, derived from a wide range of
organisms. For example, there are 136 antibodies in the Antibody Registry
that match “6E10” mentioned in the first example snippet in Table 1, but
that is the only clue about the antibody in that snippet.
Instead, we can search for detailed information about the antibodies in
the “Material and Methods” section of the paper. For example, we have
Purified anti-β-Amyloid, 1-16 antibody (6E10) (Cat. No. 803003;
RRID:AB_2564652) was obtained from … (PMID 30177812)
in “Material and Methods” that allows us to link the statement with “6E10”
to this unique antibody entity. “PMID” is the PubMed ID of the paper where
the example snippet appears.
However, several issues must be resolved for the above idea of linking
to work. First, how to identify snippets in the “Material and Methods” that
contain detailed antibody information? Next, a study may involve several
antibodies. How to use limited clues to correctly link to the right antibody
in “Material and Methods”? This is a special case of the coreference
resolution problem in Natural Language Processing (Zheng et al., 2011;
Pradhan et al., 2012), a challenging open research problem. Finally, the
information in “Material and Methods” may still be too obscure to allow
correct identification of the exact antibody used. As reported by Vasilevsky
et al. (2013), in many cases, even the authors cannot recall exactly which
antibody they have used, though the supplier name and the catalog ID
were provided to identify an antibody. To identify the supplier, the city
where the supplier is located may also be provided. The catalog IDs may
become obsolete, authors may use a short-hand syntax for supplier catalog
numbers, and suppliers may change names or merge with another company.
Without sufficient metadata, neither NLP or human experts will be able to
infer the exact antibody from the text because the required information to
correctly identify the antibody is simply not there.
All these issues can be resolved with the use of Research Resource
Identifiers (RRID) (Bandrowski et al., 2014). Precisely, we will locate
RRIDs of antibodies given in “Material and Methods” in the paper and
use the context of each RRID to guide linking of each antibody specificity
statement to the exact one or more antibody entities that it refers to. In the
example snippet above, “RRID:AB_2564652” is the RRID of the 6E10
antibody. Without it, uniquely identifying this antibody would still be
difficult based only on other information such as the catalog number “Cat.
No. 803003.”
RRIDs were developed to identify and track what research resources
were used in a given study. The antibody portion of the RRIDs is based
on the Antibody Registry (https://antibodyregistry.org/),
which assigns unique and persistent identifiers to each antibody so that
they can be referenced within publications. Unlike antibody names or
catalog numbers, these identifiers only point to a single antibody, so that
the actual antibody used can be identified by humans, search engines,
and automated agents. The identifier can be quickly traced back in the
Antibody Registry. Once an antibody is assigned an identifier and entered
into the Antibody Registry, the record will never be deleted, so even
when an antibody disappears from a vendor’s catalog or is sold to another
vendor, the provenance of that antibody can still be traced. The two million
antibody RRIDs currently in the Antibody Registry include commercial
antibodies from about 300 vendors and non-commercial antibodies from
more than 2,000 laboratories.
Authors supply RRIDs before their manuscript is published. Over
120 journals now request RRIDs to be included as part of their
instructions to authors (e.g., Cell Press, eLife, the Journal of Neuroscience,
Endocrinology, to name a few). Examples of resources that can be
identified using RRIDs include antibodies, cell lines, plasmids, model
organisms and digital tools such as databases, bioinformatics software for
statistics and data analysis, and any digital resources used in the research
workflow (Hsu et al., 2020).
If an antibody specificity statement cannot be linked to any RRID in
the paper, then the statement is most likely about an antibody that is not
used. This is one of the benefits of linking to RRIDs because authors are
instructed by the publishers to specify an RRID only when the research
resource was actually used in their study.
Figure 1 illustrates the complete workflow of our approach. Given a
full-text article from a corpus, such as PubMed Central, the workflow starts
by extracting two types of snippets in the article. One of the types consists
of “RRID mention snippets” in “Material and Methods” section. The
other type, “Specificity mention snippets,” consists of statements about
the specificity of the antibodies, usually appearing in the “Results” or
“Discussion” sections, and figure/table legends. After these snippets were
extracted, two tasks are applied to each type of snippet:
• Task 1 (Specificity classification) determines if a specificity snippet
states that the antibody is specific or not with a deep neural network
classifier.
• Task 2 (RRID linking) links each specificity statement to the exact
antibody RRID(s) that it refers to.
The output knowledge base will contain, for each entry, a triple of an
antibody, its specificity class (i.e., specific or not), and the evidence – the
snippet of the specificity statement in a source article.
3 Algorithm
3.1 Task 1 Specificity Classification
Task 1 is a three-class (positive, neutral, negative) categorization problem
given a snippet related to antibody specificity. Our solution ABSA2
is inspired from models developed for aspect-based sentiment analysis
(ABSA), a well-studied NLP problem aimed at identifying fine-grained
opinion polarity for a given aspect. Similar to formulations of many
ABSA models, in addition to the input snippet, ABSA2 also takes the
antibody term mentioned in the input snippet as our target aspect to capture
specificity expressed towards each antibody. Specifying a target antibody
is important also because there may be more than one antibody mentioned
in a snippet where their specificity may be stated differently.
In particular, ABSA2 is an attention-over-attention model (AOA)
for ABSA (Huang et al., 2018), which was originally designed on top
of context-independent word embeddings based on GLoVe (Pennington
et al., 2014). AOA worked particularly well with BERT (Devlin et al.,
2018) (RRID:SCR_018008) and other contextualized word embedding
transformers for our task over other competing ABSA models in our
experimental investigations.
Given an input snippet s = (w1, w2, . . . , wn) of n tokens and
the m target aspect tokens t = (x1, . . . , xm) (e.g., “antibody”). Our
model first employs a BERT component with L transformer layers
to calculate the corresponding contextualized representations for the
input token sequences with the form H0 = ([CLS], s,[SEP], t).
Let Hl be the output of the transformer at layer l, thus Hl =
(hl0, h
l
1, . . . , h
l
n, h
l
n+1, . . . , h
l
n+m+1) can be calculated by
Hl = Transformer(Hl−1).
Let a = (hL1 , . . . , h
L
n) and b = (h
L
n+2, . . . , h
L
n+m+1) from the
transformer’s output at the last layer. The AOA model works by first
calculating a pair-wise interaction matrix I = a · bT ∈ Rn×m, where
i
i
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Fig. 1. The workflow to construct Antibody Watch: Given the article PMC6120938, a set of “RRID mention snippets” and “Specificity mention snippets” will be extracted. Next, a
“Specificity classifier” will determine if a specificity mention snippet states that the antibody, in this case “the 6E10 antibody,” is specific to its target antigen or not. Then, “Antibody RRID
linking” will link each specificity snippet to the “RRID mention snippets,” and thus to one or more exact antibodies. In this example, “the 6E10 antibody” is linked to the antibody with
“RRID:AB_2564652,” which uniquely identifies an antibody. Finally, an entry is generated and entered into the Antibody Watch knowledge base to alert scientists that this antibody was
reported to be nonspecific in PMC6120938 (PMID 30177812).
the value of each entry Iij represents the correlation of a word pair
among the snippet and target. Let α be the column-wise softmax of I ,
representing the target-to-snippet attention, andβ be the row-wise softmax
of I , representing the snippet-to-target attention:
αij =
exp(Iij)∑n
i exp(Iij)
, βij =
exp(Iij)∑m
j exp(Iij)
.
The idea of AOA is to compute the attention weight over averaged attention
weight β ∈ R1×m by γ = αβT ∈ Rn, where
βj =
1
n
n∑
i
βij .
Then AOA computes an attention-weighted representation of the input by
rAOA = a
T · γ. (1)
Since the contextualized sentence-level representation from the last
transformer layerhL0 usually provides useful information to a classification
task, we concatenate hL0 with rAOA as the final representation of the
snippet:
rCLS = concate(hL0 , rAOA). (2)
The final prediction layer is simply a linear layer that takes either rCLS
or rAOA as the input and then followed by a softmax layer to obtain the
class conditional probability for each class. The entire model is fine-tuned
with a standard cross-entropy loss with l2 regularization.
We tested many variants of the model described above including adding
a layer of BiLSTM or multi-head attention (MHA) (Song et al., 2019)
on top of the transformer. As baselines, we also considered directly use
a transformer with or without the aspect terms. The transformers that
we compared are BERT and SciBERT (Beltagy et al., 2019). Recently,
models based on the attention-encoder network (AEN) (Song et al., 2019)
and local context focus mechanism (LCF) models (Zeng et al., 2019)
were reported to achieve state-of-the-art results for benchmark ABSA
datasets (Pontiki et al., 2016). We therefore also implemented these models
and their variants for a comparison.
3.2 Task 2 Antibody RRID Linking
Task 2 is about linking an antibody specificity snippet to a candidate
antibody RRID described in the “Material and Methods” section of the
same paper. We leveraged a BERT model as a sentence pair binary classifier
(BERT-SPC) to determine if linking an input specificity snippet to a RRID
snippet can be established. We used [SEP] token to split the specificity
snippet and the RRID snippet and the output [CLS] as the prediction,
that is, again, the standard formulation of a BERT-SPC model. We also
considered SciBERT-SPC by replacing BERT with SciBERT.
We implemented several baselines for the purpose of comparison.
One of the baselines essentially counts common non-dictionary words
in the two input snippets, e.g., “6E10” in Figure 1. The common words
were matched using the Jaro-Winkler distance (Feigenbaum, 2014). We
considered three thresholds: 1.0, 0.9, and 0.8. Another baseline is the
Siamese Recurrent Architectures (Mueller and Thyagarajan, 2016) with a
BiLSTM layer. We used either Manhattan or Euclidean distance as the last
layer to measure the similarity between the input snippet pair.
4 Implementation
4.1 Dataset Preparation
A corpus of 3,845 papers containing at least an antibody RRID in the
regex pattern AB_[0-9]+ were retrieved and 47,403 RRIDs and their
context snippets were extracted. Among these papers, 2,223 are in the
PubMed Central Open Access subset and available for text mining.
From the 2,223 full-text documents, we parsed each document into
sections and split each section into sentences using the NLTK sentence
splitter (Bird and Loper, 2004). Then we selected the sentences which
contain the regex patterns of (S|s)pecific, ((B|b)ackground
staining) or (C|c)ross( |-)reactiv to extract the antibody
specificity snippets. The sentence containing the regex patterns is placed
in the middle of the snippet surrounded by either previous or next sentence
from the context. Each snippet contains at most 3 sentences, depending
on where the key regex patterns appear. Those appearing in the figure
legend of figures or the boundary of a paragraph may consist of less than
3 sentences. The number of snippets we obtained from this process was
i
i
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22,013, from which we then chose 3,192 snippets that contained the regex
pattern (A|a)ntibod(y|ies) for further labelling. The above steps
basically extract candidate snippets that refer to antibody specificity. We
examined the rest of 19,203 snippets and could not find any related to
antibody specificity.
4.2 Data Annotation
After initial labeling of the specificity levels and RRID linkings between
the RRID and antibody snippets, we created a specialized annotation
interface within a Google Docs (RRID:SCR_005886) spreadsheet to
further annotate the training examples. In each row, the spreadsheet
interface listed the RRID snippet, followed by the supposed antibody
snippet in correlation to the RRID, and Apps Script powered cells that
allowed the curator to mark whether or not the RRID linking existed and
the specificity of the snippets to one another (Supplementary Figure 1.1).
The RRID linking choices included yes and no, while the specificity labels
included positive, neutral, and negative (Supplementary Figure 1.2 and
1.3), respectively. As an example use case, if the antibody in the antibody
snippet matched the RRID presented in the RRID snippet, then the RRID
linking would be marked as “yes.” And if the antibody snippet mentioned
that the antibody was specific, then the specificity label would be marked
as “positive.”
Furthermore, indicating the specificity classes of the antibodies
mentioned in the snippets was made easier by color highlighting
(Supplementary Figure 4). The antibody snippets were populated to
highlight the mentioned antibody in red and its specificity in blue, allowing
for easier recognition of an antibody with its proposed specificity label.
Based on this specialized annotation interface with color highlighting,
a curator would only need to continue reviewing each RRID snippet
with its antibody snippet along the row to be able to adequately identify
whether or not an RRID linking exists, as well as its identified specificity
label. As such, the interface allowed for better and easier linking and
specificity labeling practices moving forward. Two curators with antibody
lab experience contributed to the linking and labeling of these snippets.
Comparing the annotations by the two curators for 720 snippet pairs, we
obtained κ = 0.74 for the task of linking and weighted κ = 0.61 for
specificity. Weighted κ was considered because the classes were ordered.
Both are in the range of substantial agreement. These 720 pairs were
selected from the error cases from our early versions of text mining systems
and were relatively challenging to annotate. The annotations of all snippets
were then cross-examined by other authors to make final annotations
(Table 2).
As expected, the data are highly skewed to the class “specificity”
because most authors validated their antibodies either experimentally or
by citing one or more sources, but we still identified about 9.44% of cases
that were nonspecific. It is expected that there should be more neutral
statements but we filtered out most of them with keywords (missing any
mention of terms like “antibody”). For the task of RRID linking, since
specificity statements link only to a small number of all antibodies used
in a study, “yes” linking constitutes only 15.18% of pairs. Finally, the
last row of Table 2 shows the number of each specificity class of the
specificity snippets annotated in the 1,100 positive RRID linking examples.
These annotations served as our ground truth to evaluate the joint task –
combining task 1 and task 2 to extracting triples of RRID, specificity class,
and the specificity snippet to populate the Antibody Watch knowledge base.
4.3 Results
4.3.1 Task 1 Specificity Classification
Table 3 shows the results of 5-fold cross-validation for a broad range of
models for Task 1 specificity classification. Initial results comparing BERT
and SciBERT (Beltagy et al., 2019) showed that models using SciBERT
constantly outperformed their BERT counterparts so we only reported
results of the models using SciBERT. Models named with “CLS” are those
using Eq. 2 as the final snippet representation, while those without use
Eq. 1. SciBERT and SciBERT-SPC are models as baselines that use the
output term of the last layer of the transformer as the predicted class without
or with the aspect terms, respectively. We replaced the BERT layer in
AEN (Song et al., 2019) and LCF (Zeng et al., 2019) with SciBERT
and tested them with or without “CLS” as described above to create four
competing models.
Among the twelve models tested, “AOA-CLS-SciBERT” in our
ABSA2 family achieved the best overall performance and the best for
the nonspecificity (negative) class, the most important class for our aim of
providing alerts of problematic antibodies. SciBERT-SPC also performed
well as the overall second best model. Additional layers on top of the
AOA model failed to improve the overall performance, though BiLSTM
with CLS performed the best for the neutral class and can be helpful
to exclude irrelevant statements. AEN and LCF models also performed
well but fell short of our best ABSA2 model. We note that our dataset
is more unbalanced than the benchmark datasets for ABSA sentiment
analysis (Pontiki et al., 2016) yet our numbers are at about the same
level. The results suggest that our task of specificity classification can
be accomplished with our ABSA2 model.
4.3.2 Task 2 Antibody RRID Linking
A 5-fold cross-validation was applied to evaluate the performance of
each model for the RRID linking task (Table 4), in which SciBERT-SPC
performed the best, achieving 0.958 in accuracy, even though the data is
highly skewed to “no” linking. Remarkably, the baselines and the BiLSTM
Table 2. Statistics of the annotated data.
Task 1: Specificity Classification Nonspecific Neutral Specific Total
(snippets) 266 263 2,110 2,817
Task 2: RRID Linking Yes No Total
(snippet pairs) 1,100 6,145 7,245
Joint Nonspecific Neutral Specific Total
(RRID-specificity-snippet triples) 87 76 937 1,100
Table 3. Specificity classification performance comparison.
Model Specific
Non-
Neutral
Macro Weighted
Specific F1 F1
ABSA2 Models (Ours)
AOA-SciBERT 0.956 0.830 0.748 0.845 0.921
AOA-CLS-SciBERT 0.958 0.832 0.750 0.847 0.925
AOA-BiLSTM-SciBERT 0.954 0.820 0.734 0.836 0.918
AOA-BiLSTM-CLS-SciBERT 0.956 0.794 0.768 0.839 0.921
AOA-MHA-SciBERT 0.954 0.798 0.746 0.833 0.917
AOA-MHA-CLS-SciBERT 0.944 0.618 0.718 0.760 0.909
SciBERT 0.908 0.640 0.274 0.607 0.819
SciBERT-SPC 0.954 0.824 0.756 0.845 0.924
AEN-SciBERT 0.958 0.826 0.728 0.837 0.921
AEN-CLS-SciBERT 0.956 0.812 0.740 0.836 0.920
LCF-SciBERT 0.952 0.812 0.724 0.829 0.916
LCF-CLS-SciBERT 0.956 0.826 0.746 0.843 0.922
Numbers are F1; in bold fonts are the best results. Macro F1 is the average of
F1 of all classes. Weighted F1 is the average of F1 weighted by the number of
instances of each class.
i
i
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Table 4. RRID-linking performance comparison.
Model Precision Recall F1 Accuracy
BERT-SPC 0.902 0.918 0.910 0.954
SciBERT-SPC 0.914 0.932 0.923 0.958
Baseline (0.8) 0.579 0.633 0.605 0.483
Baseline (0.9) 0.591 0.665 0.626 0.600
Baseline (1.0) 0.603 0.671 0.635 0.689
BiLSTM+Manhattan 0.502 0.506 0.504 0.696
BiLSTM+Euclidean 0.522 0.536 0.529 0.664
Numbers in bold fonts are the best results.
Table 5. Complete workflow performance.
Class Truth Predicted Precision Recall F1
Nonspecific 87 101 0.802 0.931 0.862
Neutral 76 81 0.728 0.776 0.752
Specific 937 924 0.938 0.925 0.932
Total/Macro 1,100 1,106 0.823 0.878 0.848
Weighted 0.913 0.915 0.914
The last second row shows the totals for the ground truth (Truth)
and the predicted (Predicted) numbers and the macro averages of
the metrics. The last row shows the weighted metrics as defined
in the footnote of Table 3.
Siamese models are far off from the level of the performance of those with
transformers, suggesting that the task is difficult for these methods.
4.3.3 Complete Workflow
We have evaluated the performance for each individual task. We would like
to evaluate both tasks jointly as a complete workflow shown in Figure 1.
That is, how well can the workflow correctly extract triples of RRID,
specificity class and snippet as the evidence to effectively populate the
Antibody Watch knowledge base automatically?
Table 5 shows the result by joining our best performing models for
Task 1 and 2 according to Table 3 and 4, respectively, to assign RRID and
specificity class to a specificity snippet. Here, a true positive is defined
as a pair of RRID-snippet and specificity snippet where the RRID-linking
assignment is “yes” and the specificity class is the same by both ground
truth annotation and model prediction. Precision of a class C is the ratio
of the number of true positives of C and the number of all predictions
where the RRID-linking assignments are “yes” and the specificity classes
are C. Recall of a class C is the ratio of the number of true positives of
C and the number of all ground truth annotations where the RRID-linking
assignments are “yes” and the specificity classes are C.
Table 5 shows that our workflow equipped with ABSA2 for specificity
classification and SciBERT-SPC for RRID linking achieved macro F1 over
0.8 and weighted F1 over 0.9 on 5-fold cross validation.
5 Discussion
5.1 Remarkable Cases
When authors were unsure about the specificity of antibodies, we annotated
those cases as nonspecific, i.e., problematic. For example,
…A panShank antibody was also used to assay overall Shank protein
levels, with the caveat that the affinity of the PanShank antibody to
different Shank isoforms was unknown. … (PMID 2925091)
Note that a snippet contains three sentences but we only show the sentence
that illustrates the point to fit the page limit. Again, “PMID” is the PubMed
ID of the paper where the example snippet appears.
A source of confusion that puzzled both curators and our deep neural
network models is that the term “nonspecific” may be used to refer to
an antibody that is used purposefully not to target an antigen in order to
block unintended reactions or serve as a negative control in experimental
validation of antibodies. For example, here is a snippet that should be
labeled “positive.”
…The supernatant was pre-cleared by immunoprecipitation with non-
specific antibodies (NIgG) to remove and identify non-specific proteins,
which may contaminate the Atk2 Co-IP and … (PMID 26465754)
Another positive example with “nonspecific” mentioned:
To test if this effect was direct, ChIP assays were performed using
anti-E2F1 antibodies and specific primers amplifying the -214/+61
PITX1 proximal promoter region. …A nonspecific antibody was used
as a negative control, and the thymidine kinase (TK) promoter region,
containing known E2F1 binding sites, was used as a positive control
… (PMID 27802335)
Still, most snippets with “nonspecific” state that an antibody is not always
bind to its target antigen and is problematic.
…five out of six commonly used anti-Panx1 antibodies tested on
KO mouse tissue in Western blots were “non-specific” … (PMID
23390418)
ABSA2 can correctly classify all examples above as well as double
negation snippets as positive as given below.
…Negative controls for CD99 immunohistochemistry were established
on adjacent lung sections by omitting incubation with CD99 primary
antibody and did not demonstrate nonspecific binding. … (PMID
26709919)
5.2 RRID
Our approach leverages RRIDs to link a snippet about antibody specificity
to an exact antibody entity used in the reported study. Not all papers identify
antibodies with their RRIDs, but the use of RRIDs has grown steadily.
From an initial pilot in 2014 comprising approximately 25 journals, mostly
in neuroscience, the use of RRIDs has grown considerably, with RRIDs
appearing in over 1,200 journals and 21K articles. They are required by
several major journals across multiple biomedical disciplines. Over 225K
resources have been identified using the RRID specification as of March
2020. The RRID syntax was recently added to the Journal Article Tag suite
(JATS ver# 1.3d1), an XML standard for mark-up of scientific articles in
the biomedical domain, signaling that the academic publishing community
has accepted RRIDs as a standard method for tagging research resources.
The prevalence of RRID and advances in NLP will allow text
mining knowledge bases like Antibody Watch to grow into mature and
indispensable references for scientists and general public users to obtain
reliable statistics about a broad range of biomedical research resources.
The approach presented here is an example where we add “landmarks”
(i.e., RRIDs) to allow automation to become practical. This approach can
be traced back from the rails and airports for trains and airplanes to operate,
to landmarks in an automobile plant for assembly robots to calibrate, and
more recently, proposals to assign special traffic zones with signs and
rules designed for autonomous vehicles. Mons (2005) asked “why bury
it first then mine it again?” and advocated the use of semantic tagging in
scientific publication to facilitate biomedical text mining. Here, we present
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a successful use case where RRIDs serve as the landmarks for text mining
robots, making detecting antibody specificity feasible and reliable.
5.3 Future Work
We plan to extend and replicate the general approach of integrating
RRID with advanced deep neural network NLP models to quantify impact
and influence of research resources by automated text mining. We will
develop more text mining systems to extract quality statements about
other research resources, including cell lines, data repositories, statistics
and bioinformatics tools, etc. These statements will be made available
through the “Resource Reports” developed by the NIDDK Information
Network (dkNET.org). Resource Reports aggregate information based on
RRIDs into a single report. Information includes basic information about
the resource, papers that use the resource and any known issues regarding
its performance. In a previous study (Babic et al., 2019), we showed that
the use of RRIDs for cell lines correlated with a dramatic decrease in the
number of papers published using problematic cell lines. We speculate
that because when authors search the resource database for cell lines to
obtain an RRID, they are confronted with a warning when the cell line
is contaminated or misidentified. We hope to achieve the same type of
alerting service for other types of resources like antibodies.
5.4 Conclusion
In this work we present a novel approach to the antibody specificity
problem by automated text mining and show that the approach is feasible.
We formulated the problem and divided it into two tasks: 1) extracting
and classifying snippets about antibody specificity and 2) linking the
extracted snippets to antibodies that they refer to. We created a set of
ground truth from two thousand articles reporting studies using antibodies
as experimental reagents. We proposed an approach leveraging RRID to
solve the challenging antibody identification problem and developed deep
neural network models based on SciBERT to achieve weighted F1 scores
over 0.9 for both tasks individually and the joint task when the two tasks
combined to complete the workflow, where antibody specificity statements
are extracted and assigned to exact antibody entities unambiguously. We
will continue annotating more training examples to boost the performance.
The approach will scale to the ever growing number of publications and
antibodies and provide scientists a reliable source about the specificity of
antibodies.
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